Plozasiran Reduces Triglyceride Levels by 74% at 24 Weeks
Novel drug shows promise for treating severe hypertriglyceridemia in patients at high risk for pancreatitis
Daniel Gaudent Daniel Gaudet University Of Montreal American College Of Cardiology Annual Scientific Session Arrowhead Pharmaceuticals American College
Source: dicardiology.com